Research and Markets: Cardiac Biomarkers - Global Strategic Business Report

DUBLIN--(BUSINESS WIRE)--Research and Markets(http://www.researchandmarkets.com/research/f265da/cardiac_biomarkers) has announced the addition of the "Cardiac Biomarkers - Global Strategic Business Report" report to their offering.

“Cardiac Biomarkers - Global Strategic Business Report”

This report analyzes the worldwide markets for Cardiac Biomarkers in US$ Million. The market is analyzed by Location-wise (Clinical Laboratory Testing, and Point-of-Care Testing) and by Assay types (Acute Myocardial Infarction (AMI) Tests (Creatine Kinase-MB (CK-MB), Cardiac Troponin, & Myoglobin), and Congestive Heart Failure (CHF) Tests (BNP &NT-proBNP)). The report provides separate omprehensive analytics for the US, Europe, and Rest of the World. Annual estimates and forecasts are provided for the period 2009 through 2017. A six-year historic analysis is also provided for these markets. The report profiles 58 companies including many key and niche players such as Abbott Diagnostics, Alere, Inc., Ani Biotech Oy, Axis-Shield PoC, Beckman Coulter, Inc., BG Medicine, biomrieux, LifeSign LLC, Nanogen Inc., Ortho-Clinical Diagnostics, Inc., Prognostix, Inc., Response Biomedical Corp., Roche Diagnostics Corp., and Siemens Healthcare Diagnostics, Inc..Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.

Key Topics Covered:

1. Introduction, Methodology & Product Definitions 2. Industry Overview 3. Trends in Research and Development 4. Cardiac Markers and Myocardial Infarction 5. Cardiac Markers and Congestive Heart Failure (Chf) 6. Other Important Cardiac Biomarkers 7. Cardiac Biomarker Testing in Clinical Laboratories 8. Cardiac Biomarkers at Point-of- Care Testing 9. Strategic Corporate Developments 10. Product Launches/Developments/ Approvals 11. Focus on Select Global Players 12. Global Market Perspective 13. the United States 14. Europe 14A. France 14B. Germany 14C. Italy 14D. the United Kingdom 14E. Rest of Europe 15. Rest of World

Companies Mentioned:

• Abbott Diagnostics
• Alere Inc.
• Ani Biotech Oy
• Axis-Shield PoC
• Beckman Coulter Inc.
• BG Medicine
• biomrieux
• LifeSign LLC
• Nanogen Inc.
• Ortho-Clinical Diagnostics Inc.
• Prognostix Inc.
• Response Biomedical Corp.
• Roche Diagnostics Corp.
• Siemens Healthcare Diagnostics Inc

For more information visit http://www.researchandmarkets.com/research/f265da/cardiac_biomarkers